Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

Modulatory effect of gastric pentadecapeptide BPC 157 on

. 2009 Dec:60 Suppl 7:191-6. Affiliations PMID: 20388964 Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing L Brcic et al. J Physiol Pharmacol. 2009 Dec. Abstract Angiogenesis is a natural and complex process controlled by angiogenic and angiostatic molecules, with a central role in healing process. One of the most important modulating factors in angiogenesis is the vascular endothelial growth factor (VEGF). Pentadecapeptide BPC 157 promotes healing demonstrating particular angiogenic/angiomodulatory potential. We correlated the angiogenic effect of BPC 157 with VEGF expression using in vitro (cell culture) and in vivo (crushed muscle and transected muscle and tendon) models. Results revealed that there is no direct angiogenic effect of BPC 157 on cell cultures. On the other hand, immunohistochemical analysis of muscle and tendon healing using VEGF, CD34 and FVIII antibodies showed adequately modulated angiogenesis in BPC 157 treated anim

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

. 2009 Dec:60 Suppl 7:191-6.

Affiliations

PMID: 20388964

Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing

L Brcic et al. J Physiol Pharmacol. 2009 Dec.

Abstract

Angiogenesis is a natural and complex process controlled by angiogenic and angiostatic molecules, with a central role in healing process. One of the most important modulating factors in angiogenesis is the vascular endothelial growth factor (VEGF). Pentadecapeptide BPC 157 promotes healing demonstrating particular angiogenic/angiomodulatory potential. We correlated the angiogenic effect of BPC 157 with VEGF expression using in vitro (cell culture) and in vivo (crushed muscle and transected muscle and tendon) models. Results revealed that there is no direct angiogenic effect of BPC 157 on cell cultures. On the other hand, immunohistochemical analysis of muscle and tendon healing using VEGF, CD34 and FVIII antibodies showed adequately modulated angiogenesis in BPC 157 treated animals, resulting in a more adequate healing. Therefore the angiogenic potential of BPC 157 seems to be closely related to the healing process in vivo with BPC 157 stimulating angiogenesis by up-regulating VEGF expression.

PubMed Disclaimer

Connected topics

Follow this recovery question